U.S. Treasury Houses CFIUS Committee Amid Proposed Biotech Investment Act
2 reports, 1 independent
Updated Oct 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The U.S. Treasury houses the Committee on Foreign Investment in the United States (CFIUS). CFIUS reviews capital inflows into U.S. companies, rather than outflows. The bipartisan Biotech Investment National Security Act of 2026 proposes amendments to the COINS Act to govern this process.
From wbkb11.com
Why it matters
The proposed legislation would expand the sectors reviewed by CFIUS to include biotechnology. This change would also grant the U.S. Treasury one year to establish the necessary rules for implementing these new requirements.
From wbkb11.com
Who's involved
- U.S. TreasuryThe U.S. Treasury houses the CFIUS committee responsible for reviewing foreign investment in U.S. companies.
Keep exploring
The entities involved
-
U.S. Treasury
mine in Sierra County, New Mexico, United States of America